Rusch VW - Search Results

1

Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial.

Chaft JE, Oezkan F, Kris MG, Bunn PA, Wistuba II, Kwiatkowski DJ, Owen DH, Tang Y, Johnson BE, Lee JM, Lozanski G, Pietrzak M, Seweryn M, Byun WY, Schulze K, Nicholas A, Johnson A, Grindheim J, Hilz S, Shames DS, Rivard C, Toloza E, Haura EB, McNamee CJ, Patterson GA, Waqar SN, Rusch VW, Carbone DP; LCMC study investigators. Chaft JE, et al. Among authors: rusch vw. Nat Med. 2022 Oct;28(10):2155-2161. doi: 10.1038/s41591-022-01962-5. Epub 2022 Sep 12. Nat Med. 2022. PMID: 36097216 Free PMC article. Clinical Trial.

2

Survival after resection of stage II non-small cell lung cancer.

Martini N, Burt ME, Bains MS, McCormack PM, Rusch VW, Ginsberg RJ. Martini N, et al. Among authors: rusch vw. Ann Thorac Surg. 1992 Sep;54(3):460-5; discussion 466. doi: 10.1016/0003-4975(92)90435-7. Ann Thorac Surg. 1992. PMID: 1324654 Free article.

3

Ras oncogene point mutation: an infrequent event in bronchioloalveolar cancer.

Rusch VW, Reuter VE, Kris MG, Kurie J, Miller WH Jr, Nanus DM, Albino AP, Dmitrovsky E. Rusch VW, et al. J Thorac Cardiovasc Surg. 1992 Nov;104(5):1465-9. J Thorac Cardiovasc Surg. 1992. PMID: 1331621

4

Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung cancer.

Rusch V, Klimstra D, Venkatraman E, Oliver J, Martini N, Gralla R, Kris M, Dmitrovsky E. Rusch V, et al. Cancer Res. 1995 Nov 1;55(21):5038-42. Cancer Res. 1995. PMID: 7585548

5

Molecular biologic features of non-small cell lung cancer. Clinical implications.

Rusch VW, Dmitrovsky E. Rusch VW, et al. Chest Surg Clin N Am. 1995 Feb;5(1):39-55. Chest Surg Clin N Am. 1995. PMID: 7743147 Review.

6

Adjuvant and neoadjuvant therapy for stages I through III non-small cell lung cancer.

Rusch VW. Rusch VW. Ann Thorac Surg. 1994 Sep;58(3):899-900. doi: 10.1016/0003-4975(94)90785-4. Ann Thorac Surg. 1994. PMID: 7944732 No abstract available.

7

Management of non-small cell lung cancer with direct mediastinal involvement.

Martini N, Yellin A, Ginsberg RJ, Bains MS, Burt ME, McCormack PM, Rusch VW. Martini N, et al. Among authors: rusch vw. Ann Thorac Surg. 1994 Nov;58(5):1447-51. doi: 10.1016/0003-4975(94)91933-x. Ann Thorac Surg. 1994. PMID: 7979673

8

Neoadjuvant therapy: a novel and effective treatment for stage IIIb non-small cell lung cancer. Southwest Oncology Group.

Rusch VW, Albain KS, Crowley JJ, Rice TW, Lonchyna V, McKenna R Jr, Stelzer K, Livingston RB. Rusch VW, et al. Ann Thorac Surg. 1994 Aug;58(2):290-4; discussion 294-5. doi: 10.1016/0003-4975(94)92195-4. Ann Thorac Surg. 1994. PMID: 8067822 Clinical Trial.

9

Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial.

Rusch VW, Albain KS, Crowley JJ, Rice TW, Lonchyna V, McKenna R Jr, Livingston RB, Griffin BR, Benfield JR. Rusch VW, et al. J Thorac Cardiovasc Surg. 1993 Jan;105(1):97-104; discussion 104-6. J Thorac Cardiovasc Surg. 1993. PMID: 8380477 Clinical Trial.

10

NR-LU-10 monoclonal antibody scanning. A helpful new adjunct to computed tomography in evaluating non-small-cell lung cancer.

Rusch V, Macapinlac H, Heelan R, Kramer E, Larson S, McCormack P, Burt M, Martini N, Ginsberg R. Rusch V, et al. J Thorac Cardiovasc Surg. 1993 Aug;106(2):200-4. J Thorac Cardiovasc Surg. 1993. PMID: 8393504 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

482 results

Search Page